Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Immunotherapy including CAR-T Therapy

Session: BiTE The Dust: T Cell-Engaging Antibody Therapies to Eliminate Autoreactive Immune Compartments in Rheumatic Diseases

T-Cell Engagers in Oncologic Indication

Monday, October 27, 2025
8:30 AM – 9:00 AM Central Time

    Speaker(s)

  • LF

    Lorenzo Falchi, MD

    Memorial Sloan Kettering Cancer Center
    New York, New York, United States

    Disclosure(s): AbbVie, Genentech, ADC therapeutics, Seagen, Ipsen, Johnson & Johnson: Advisor or Review Panel Member (Ongoing); Genmab, AbbVie, Roche, Kite: Travel Support (Ongoing); Roche, Genentech, Genmab, AbbVie, Innate Pharma, Beigene, Astrazeneca: Grant/Research Support (Ongoing); Roche, Genentech, Genmab, AbbVie, Sanofi, Evolveimmune, Astrazeneca, Merck: Consultant (Ongoing); Roche, Genmab, AbbVie, Kite: Honoraria (Ongoing)